Psyence Biomedical (PBM) Non-Current Assets (2022 - 2026)

Psyence Biomedical has reported Non-Current Assets for 5 years, with the latest figure at $8.5 million in Q1 2026.

• On a quarterly basis, Non-Current Assets rose 1018.48% year-over-year to $8.5 million in Q1 2026; TTM through Mar 2026 was $14.4 million, a 8.43% increase from a year earlier, with the FY2026 full-year figure at $8.5 million, up 1018.48% from the prior year.
• Non-Current Assets was $8.5 million for Q1 2026 at Psyence Biomedical, up from $5.2 million in the prior quarter.
• The five-year high for Non-Current Assets was $257.7 million in Q4 2022, with the low at $10126.0 in Q3 2024.
• Average Non-Current Assets over 5 years is $47.4 million, with a median of $6.8 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets plunged 99.92% in 2024, then jumped 51062.26% in 2025.
• Over 5 years, Non-Current Assets stood at $257.7 million in 2022, then slumped by 95.14% to $12.5 million in 2023, then slumped by 99.92% to $10126.0 in 2024, then surged by 51062.26% to $5.2 million in 2025, then jumped by 63.24% to $8.5 million in 2026.
• The last three Non-Current Assets figures came in at $8.5 million (Q1 2026), $5.2 million (Q3 2025), and $756096.0 (Q1 2025), per Business Quant data.